BLRX is especially a strong buy now. Their newest drug "weeds out" and kills bone marrow cancer. Plus an amazing additional pipeline. And their stock only went up a few percentage points with news of extremely positive phase II results.
Stock is highly undervalued and on sale again today. Only a matter of time before it gets the attention. It is looking like a very strong long term investment with only a 69 million dollar market cap. Multiple pipelines and positive results over the last month